Evoltra and neutropenic sepsis Patient Reports February 13, 2012
Evoltra Side Effects Report #6139727-2
Evoltra side effect was reported by a Health Professional from UNITED KINGDOM on Mar 16, 2009. Female patient, 77 years of age, was diagnosed with myeloid leukaemia and was treated with Evoltra. After drug was administered, patient experienced the following side effects: acute myeloid leukaemia, cardiac arrest
, clostridium difficile toxin test positive, left ventricular failure, myocardial ischaemia, neutropenic sepsis, renal failure acute. Evoltra dosage: 42 MG, QDX5, INTRAVENOUS. During the same period patient was treated with DAUNORUBICIN, LEVOTHYROXINE, ALLOPURINOL, ACETAMINOPHEN, ONDANSETRON. Patient was hospitalized. Patient died on 01/25/2009.Evoltra Side Effects Report #6074383-3
Evoltra side effect was reported by a Physician from UNITED STATES on Jan 29, 2009. Female patient, 77 years of age, was diagnosed with acute myeloid leukaemia and was treated with Evoltra. After drug was administered, patient experienced the following side effects: acute myeloid leukaemia, cardiac arrest
, neutropenic sepsis, renal failure acute. Evoltra dosage: unknown. During the same period patient was treated with DAUNORUBICIN. Patient was hospitalized. Patient died on 01/25/2009.Evoltra Side Effects Report #6106875-2
Evoltra side effect was reported by a Physician from UNITED KINGDOM on Feb 20, 2009. Female patient, 77 years of age, was diagnosed with acute myeloid leukaemia and was treated with Evoltra. After drug was administered, patient experienced the following side effects: acute myeloid leukaemia, myocardial ischaemia, neutropenic sepsis, renal failure acute. Evoltra dosage: unknown. During the same period patient was treated with DAUNORUBICIN. Patient was hospitalized. Patient died on 01/25/2009.
Evoltra and neutropenic sepsis 